no image available Dickens & Co. "Hope in the Face of Cancer: Evaluating the Safety of Imatinib Mesylate in Iraqi Patients with Chronic Myeloid Leukemia" "A Single-Center Study Unpacking the Efficacy and Tolerability of Imatinib Mesylate in the Battle Against Chronic Phase CML" Price: 23.00€